OQROSign up free
Insider trade

Nextcure (NXTC): 10% owner bought ~$27K

ADAR1 Capital Management, 10% owner at Nextcure, bought ~$27K of Nextcure shares.

~$27K
Approx. value · 5,626 sh @ $4.83
728K
Holds after · shares reported
Traded
Oct 23, 2026
Filed
Oct 27, 2026

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Sep 3, 2026Company filing · Form 8-K · Material agreementSigned an important agreement
  2. Oct 20, 20265% stakeJP Sailing Capital Ltd reported a passive stake (13G) of 9.9%
  3. Oct 23, 2026 · this disclosureInsider · 3 days before an 8-K10% owner purchased ~$27K of NXTC shares in the open market

What came next

  1. Oct 26, 2026Company filing · Form 8-K · Executive changeChanged a top executive or board member“On October 26, 2026 NextCure, Inc. (the “Company”) determined that the employment of Dr. Udayan Guha, M.D., Ph.D., Chief Medical Officer and a named executive officer of the Company, will be terminated effective October 31, 2026, in contemplation of the pending merger of the Company and Avere Therapeutics, Inc (the “Merger”). ​ In connection with his departure, Dr. Guha entered into a severance agreement and release…”
  2. Oct 26, 2026Insider10% owner purchased ~$8.4K of NXTC shares in the open market
  3. Oct 27, 2026Insider · 14 days before results10% owner purchased ~$18K of NXTC shares in the open market
  4. Nov 5, 2026Insider · 5 days before results10% owner purchased ~$5.2K of NXTC shares in the open market
  5. Nov 6, 2026Insider · 4 days before results10% owner purchased ~$19K of NXTC shares in the open market
  6. Nov 10, 2026Company filing · Form 8-K · ResultsReported its results
  7. Nov 11, 2026Insider10% owner purchased ~$63K of NXTC shares in the open market
  8. Nov 13, 20265% stakeAffinity Asset Advisors, LLC reported a passive stake (13G) of 10.0%
View the official recordSEC Form 4

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Nextcure

For Nextcure, OQRO holds 6 insider filings (SEC Form 4 or Form 144) and 1 fund holdings report (13F) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its NXTC page.

Other recent filings by ADAR1 Capital Management, LLC, 10% owner

The full history of ADAR1 Capital Management, LLC, 10% owner is on the profile page.

How this filing works

Explore the data

Other disclosures at Nextcure

Everything OQRO holds on this company is on its NXTC page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

Sign up freeAlready have an account? Log in

OQRO is free for everyone. No card, no trial

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data